Progression To Pivotal Study Following Positive Interim Data In Male Androgenetic Alopecia Announced By Follica

Follica Announces Progression to Pivotal Study Following Positive Interim Data in Male Androgenetic Alopecia. Follica, Inc, a clinical-stage biotech developing a regenerative platform for hair growth, today announced positive interim data from an ongoing safety and optimization study to treat hair loss in male androgenetic alopecia.

URL:
businesswire.com/news/home/20190612005883/en/Follica-Announces-Progression-Pivotal-Study-Positive-Interim